Lea E. Widdice, MD Assistant Professor of Pediatrics, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH
Jessica A. Kahn, MD, MPH Associate Professor of Pediatrics, Director, Research Training, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH; Steering Committee, National Network for Immunization Information; HPV Expert Advisory Group,World Health Organization
Address: Lea E. Widdice, MD, Division of Adolescent Medicine, MLC 4000, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229; e-mail lea.widdice@cchmc.org
Dr. Kahn has disclosed that she has received a consulting fee from the SciMed and Merck corporations for editing a journal supplement on HPV vaccines.
ABSTRACTGardasil, a vaccine against human papillomavirus (HPV), recently became available in the United States for use in girls and women 9 to 26 years of age. A second HPV vaccine, Cervarix, is under development. These vaccines constitute the most significant development in cervical cancer prevention in the last 60 years, having the potential to reduce the incidence of cervical cancer by up to 70%
